Review: Orlistat, sibutramine, and rimonabant reduce weight in overweight and obese persons

TherapeuticsMarch 1, 2008Review: Orlistat, sibutramine, and rimonabant reduce weight in overweight and obese personsAlka M. Kanaya, MDAlka M. Kanaya, MDUniversity of California, San Francisco, San Francisco, California, USA (A.M.K.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2008-148-2-050 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationRucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335:1194-9. https://pubmed.ncbi.nlm.nih.gov/18006966Clinical Impact RatingsGIM/FP/GP: Endocrinology: References1 Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107:1755-67. [PMID: 17904936] Google Scholar2 Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52. [PMID: 17715408] Google Scholar Author, Article, and Disclosure InformationAffiliations: University of California, San Francisco, San Francisco, California, USA (A.M.K.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Current IssueMarch 1, 2008Volume 148, Issue 2Page: 50KeywordsAdverse eventsBlood pressureCholesterolConstipationDietDrugsEndocrinologyExerciseFactor analysisHealth care quality assessmentInformation storage and retrievalInsomniaLipoproteinsMedical risk factorsMorbidityMouthNauseaObesityOverweightWeight loss ePublished: 4 March 2020 Issue Published: March 1, 2008 Copyright & PermissionsCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...